J-Plasma and Renuvion: Uses, Limits and Questions to Ask
Dr. Smith does not offer J-Plasma or Renuvion. This page explains the device for patients comparing their options.
J-Plasma and Renuvion are names you may encounter when researching treatment for loose skin. Before comparing a device with liposuction or a skin-removal procedure, establish exactly what is proposed: the handpiece, the treatment area, whether it will be used beneath the skin or on its surface, and whether liposuction is part of the operation.
Why Dr. Smith prefers BodyTite
Dr. Smith prefers BodyTite because its bipolar design directs radiofrequency energy between an electrode beneath the skin and one on the skin’s surface. The Renuvion APR handpiece uses monopolar radiofrequency delivered through helium plasma.
Dr. Smith favors BodyTite’s localized energy path and temperature and impedance monitoring for the control they give him over the direction and intensity of energy delivered. He uses these controls with the aim of limiting the risk of thermal injury. Energy-based treatments can still cause burns.
FDA: Renuvion APR device description; BodyTite: electrode arrangement and energy monitoring.
What the device does
The Renuvion/J-Plasma system uses radiofrequency energy and helium to produce plasma. Its energy heats tissue. The procedure and its risks depend on the particular handpiece and how it is used; the name alone does not describe a complete treatment plan.
FDA clearance is specific to the handpiece and use
The FDA’s May 2023 update distinguishes two aesthetic applications. The APR handpiece has a clearance for improving loose skin in the neck and beneath the chin. A separate Dermal handpiece has a clearance for treating moderate to severe wrinkles in Fitzpatrick skin types I, II and III. The Dermal handpiece’s skin-type limits should not be presented as a blanket description of every Renuvion procedure.
FDA: handpiece-specific indications.
The APR handpiece also received clearance in April 2023 to coagulate soft tissue beneath the skin after liposuction for body contouring. That wording describes a particular use. It does not establish that every proposed treatment area, combination or result is appropriate for you.
Why older warnings and newer clearances can both appear
The FDA warned about aesthetic uses in March 2022, before the later handpiece-specific clearances described above. An older warning should therefore be read alongside the subsequent updates. Equally, a later clearance should not be treated as a promise of a risk-free procedure.
Discuss risks and the plan for follow-up
The FDA’s 2022 communication described reports of serious injuries, including burns, infection, scarring, changes in skin color, nerve damage, bleeding, and gas collecting in tissues or blood vessels. These historical reports do not supply a personal complication rate. Ask the treating clinician to explain the current device instructions, risks relevant to your plan, and how a suspected complication would be handled.
Questions to bring to a consultation
- What is causing the feature I want to change: fat, loose skin, or another aspect of my anatomy?
- Which handpiece and treatment area are proposed, and how does the plan relate to its current labeling?
- What improvement is realistic, and what would remain unchanged?
- How do the alternatives compare, including observation, liposuction without added energy, or an operation that removes skin?
- What anesthesia, recovery support and follow-up would be needed?
- Who would assess me if I developed a problem after treatment?
Ask for an explanation you can use to make a decision, rather than choosing from a device name or an advertised tightening claim. For background on another approach described on this site, read about BodyTite. A consultation can help distinguish what different procedures are intended to address.